Syntheses of pharmaceutically active small molecules
Ended Purchase Order Awarded Last action
- Contract number
- HHSN271201700037A
- Awardee
-
Pharmaron, Inc. UEI L8NQAFSTPSY9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $281,751
Award facts
- Opportunity
-
- HHSNIHNIDASSSASS17601 Solicitation number
- Synthesis of pharmaceutically active small molecules Award Notice · Posted Sep 17, 2017
- Synthesis of pharmaceutically active small molecules Award Notice · Posted Jul 21, 2017
- Contract value 100% obligated
- $281,751.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Louisville, KY 40202, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$93,249 | |
| Original award | $375,000 |
About this award
This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Pharmaron, Inc., a global contract research organization. The $281,751.22 purchase order contract is for a firm fixed price and does not have a set-aside designation. Under this contract, Pharmaron is conducting a variety of drug development activities to support the work of the NIH's National Center for Advancing Translational Sciences (NCATS), including toxicity studies, formulation development, pharmacokinetic assessments, and ion channel testing in rodents. The contract has a performance period from September 2017 to September 2018 and was awarded to Pharmaron's division located in China. Pharmaron has received over 30 similar prime contracts from HHS/NIH since 2019 totaling over $1.5 million to advance potential new therapies through the translational research pipeline.
Quick answers
Who was awarded contract HHSN271201700037A?
HHSN271201700037A was awarded to Pharmaron, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 22, 2017.
How much is contract HHSN271201700037A worth?
The government has obligated $281,751 on HHSN271201700037A.
Was contract HHSN271201700037A competed?
The extent of competition for HHSN271201700037A was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award